Video » SHDS 2018: Point: TAVR will be the Treatment of Choice for Bicuspid Aortic Valve Disease in the Future! June 26, 2018
Video » Live Case SHDS 2018: Live Case #5: Cedars-Sinai Medical Center, Los Angeles, CA - TAVR June 26, 2018
Video » SHDS 2018: An Introduction to “VARC-3: A Focused Update” – New Endpoints and Definitions for Aortic Valve Clinical Research June 26, 2018
Video » SHDS 2018: New Standards for SAVR and TAVR Bioprosthetic Valve Dysfunction and Failure: A Consensus Statement from EAPCI, ESC, and EACTS June 26, 2018
Video » SHDS 2018: Counterpoint: Most Bicuspid Aortic Valves (Especially In Younger Low-Risk Patients) Will Remain in the Surgical Domain! June 26, 2018
Video » SHDS 2018: Embedding 'Shared Decision-Making' as a Fundamental Component of Clinical Research, Regulatory Device Approval, and Clinical Practice June 26, 2018
Video » SHDS 2018: Perspectives From the NEW Multi-society (AATS, ACCF, SCAI, and STS) Expert Consensus Statement on TAVR Operator and Institutional Requirements June 26, 2018
Video » SHDS 2018: Multisociety Appropriate Use Criteria for the Treatment of Patients With Severe Aortic Stenosis: A Useful Guide for Clinical Decision-Making? June 26, 2018
Video » SHDS 2018: Perspectives on the Hierarchy of Valve Centers of Excellence in the U.S. June 26, 2018
Video » SHDS 2018: TAVR and SAVR Therapy: Reconciling the Recent Society (ACC/AHA/ESC/EACTS) Guidelines With Clinical Practice Trends June 26, 2018